10.11
+0.02(+0.20%)
Currency In USD
| Previous Close | 10.09 |
| Open | 10.09 |
| Day High | 10.22 |
| Day Low | 9.43 |
| 52-Week High | 34.71 |
| 52-Week Low | 6.32 |
| Volume | 760,644 |
| Average Volume | 812,357 |
| Market Cap | 415.69M |
| PE | -11.49 |
| EPS | -0.88 |
| Moving Average 50 Days | 10.71 |
| Moving Average 200 Days | 11.42 |
| Change | 0.02 |
If you invested $1000 in RxSight, Inc. (RXST) since IPO date, it would be worth $631.88 as of January 14, 2026 at a share price of $10.11. Whereas If you bought $1000 worth of RxSight, Inc. (RXST) shares 3 years ago, it would be worth $777.09 as of January 14, 2026 at a share price of $10.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
GlobeNewswire Inc.
Jan 11, 2026 2:30 PM GMT
ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preli
RxSight, Inc. Announces Chief Financial Officer Transition
GlobeNewswire Inc.
Dec 22, 2025 10:15 PM GMT
ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Compan
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
GlobeNewswire Inc.
Nov 20, 2025 9:05 PM GMT
ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today anno